THE Food and Drug Administration (FDA) has given its emergency use authorization (EUA) approval to the coronavirus disease 2019 (Covid-19) vaccine made by British-Swedish drugmaker AstraZeneca.

During the Laging Handa media briefing on Thursday, FDA Director-General Rolando Enrique Domingo said that the interim data for AZD1222 from its ongoing phase three trials had an efficacy of 70 percent.

Subscribe to unlock this article
Premium Subscription
P 80 per month
(billed annually at P 960)
  • Unlimited ad-free access to website articles
  • Access to subscriber exclusive website contents
  • Access to the Digital Edition (up to 3 devices)

TRY FREE FOR 30 DAYS